Mass cytometry of acute B cell lymphoblastic leukemias at diagnosis reveals intrapatient phenotypic heterogeneity and specific signatures that mimic cell developmental stage and predict future relapse.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nowell, P.C. Science 194, 23–28 (1976).
Ferrando, A.A. & López-Otín, C. Nat. Med. 23, 1135–1145 (2017).
Hunger, S.P. & Mullighan, C.G. N. Engl. J. Med. 373, 1541–1552 (2015).
Bhojwani, D. & Pui, C.H. Lancet Oncol. 14, e205–e217 (2013).
Ma, X. et al. Nat. Commun. 6, 6604 (2015).
Good, Z. et al. Nat. Med. 24, 474–483 (2018).
Spitzer, M.H. & Nolan, G.P. Cell 165, 780–791 (2016).
Behbehani, G.K. Clin. Lab. Med. 37, 945–964 (2017).
Somasundaram, R., Prasad, M.A., Ungerbäck, J. & Sigvardsson, M. Blood 126, 144–152 (2015).
Macaulay, I.C., Ponting, C.P. & Voet, T. Trends Genet. 33, 155–168 (2017).
Frei, A.P. et al. Nat. Methods 13, 269–275 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Martín-Subero, J. Predicting leukemia relapse. Nat Med 24, 385–387 (2018). https://doi.org/10.1038/nm.4529
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4529
